CFG
BPMC

Citizens Financial Group’s Blueprint Medicines BPMC Stock Holding History

Citizens Financial Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,967
Closed -$508K – 797
2025
Q2 		$508K Buy
3,967
+30
+0.8% +$3.12K 0.01% 466
2025
Q1 		$348K Buy
3,937
+15
+0.4% +$1.46K 0.01% 477
2024
Q4 		$342K Buy
3,922
+4
+0.1% +$366 0.01% 455
2024
Q3 		$362K Sell
3,918
-11
-0.3% -$1.09K 0.01% 433
2024
Q2 		$423K Buy
+3,929
New +$393K 0.01% 393

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citizens Financial Group's BPMC Position: Q3 2025 in Review

Citizens Financial Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 3,967 shares — an estimated $508K sold.

Citizens Financial Group first reported a position in BPMC in Q2 2024 and held it in 5 quarters. The position peaked at $508K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Citizens Financial Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Citizens Financial Group sold 3,967 Blueprint Medicines shares in Q3 2025, an estimated $508K.
  • Citizens Financial Group first reported a position in Blueprint Medicines in Q2 2024 and held it in 5 quarters.
  • Citizens Financial Group's Blueprint Medicines position peaked at $508K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Citizens Financial Group's 13F filing for Q3 2025, filed 24 Oct 2025.